Tools   Select Another Resource Report Type

http://pga.mgh.harvard.edu/oligopicker/

Software to help selecting up to five oligo probes for each of the DNA sequences you provided for microarray spotting.

Proper citation: OligoPicker (RRID:SCR_008720) Copy   

•   Source: SciCrunch Registry

http://www.opentox.org/dev/apis/api-1.1/structure

Tools for the integration of data from various sources (public and confidential), for the generation and validation of computer models for toxic effects, libraries for the development and seamless integration of new algorithms, and scientifically sound validation routines. The goal of OpenTox is to develop an interoperable predictive toxicology framework which may be used as an enabling platform for the creation of predictive toxicology applications. OpenTox is relevent for users from a variety of research areas: Toxicological and chemical experts (e.g. risk assessors, drug designers, researchers) computer model developers and algorithm developers non specialists requiring access to Predictive Toxicology models and data OpenTox applications can combine multiple web services providing users access to distributed toxicological resources including data, computer models, validation and reporting. Applications are based on use cases that satisfy user needs in predictive toxicology. OpenTox was initiated as a collaborative project involving a combination of different enterprise, university and government research groups to design and build the initial OpenTox framework. Additionally numerous organizations with industry, regulatory or expert interests are active in providing guidance and direction. The goal is to expand OpenTox as a community project enabling additional expert and user participants to be involved in developments in as timely a manner as possible. To this end, our mission is to carry out developments in an open and transparent manner from the early days of the project, and to open up discussions and development to the global community at large, who may either participate in developments or provide user perspectives. Cooperation on data standards, data integration, ontologies, integration of algorithm predictions from different methods, and testing and validation all have significant collaboration opportunities and benefits for the community. OpenTox is working to meet the requirements of the REACH legislation using alternative testing methods to contribute to the reduction of animal experiments for toxicity testing. Relevant international authorities (e.g., ECB, ECVAM, US EPA, US FDA) and industry organizations participate actively in the advisory board of the OpenTox project and provide input for the continuing development of requirement definitions and standards for data, knowledge and model exchange. OpenTox actively supports the development and validation of in silico models and algorithms by improving the interoperability between individual systems (common standards for data and model exchange), increasing the reproducibility of in silico models (by providing a quality source of structures, toxicity data and algorithms) and by providing scientifically sound and easy-to-use validation routines. OpenTox is committed to the support and integration of alternative testing methods using in vitro assay approaches, systems biology, stem cell technology, and the mining and analysis of human epidemiological data. Hence the framework design must take into account extensibility to satisfy a broad range of scientific developments and use cases.

Proper citation: OpenTox Framework (RRID:SCR_008686) Copy   

•   Source: SciCrunch Registry

http://www.procure.ca/index.php

The main goal of PROCURE is to provide science and humanity with means to help prevent and cure prostate cancer a disease which this year alone will be diagnosed in an estimated 25,500 Canadian men and one which will, on average, take the lives of 85 men every week. PROCURE strives to redefine the boundaries of research and knowledge by: * Initiating an on-going dialogue with the public and healthcare community to provide needed information and support through accessible means such as: ** A comprehensive website in French and English ** Lectures and special events ** Free book on prostate cancer * Funding and structuring over time a bank of biological materials and data on men with prostate cancer as well as those at risk of developing the disease. Such a Biobank, as it is known, will accelerate breakthrough scientific discovery. Join our alliance today by informing yourself and loved ones. Encourage the other men you care about to have an examination. Make a contribution to our cause. Help us keep information on this site up-to-date. In doing so you will become part of the force against prostate cancer!

Proper citation: PROCURE (RRID:SCR_008722) Copy   

•   Source: SciCrunch Registry

http://dc.crs4.it/projects/biodoop

A suite of parallel bioinformatics applications based upon a popular open-source Java implementation of MapReduce, Hadoop.

Proper citation: Biodoop (RRID:SCR_008711) Copy   

•   Source: SciCrunch Registry

http://www.scioncorp.com/pages/product_prices.htm#Software

THIS RESOURCE IS NO LONGER IN SERVICE, documented on July 17, 2013. Commercial software vendor.

Proper citation: Scion Image (RRID:SCR_008673) Copy   

•   Source: SciCrunch Registry

http://code.google.com/p/drgap/

Designed to identify Driver Genes and Pathways in cancer genome sequencing studies.

Proper citation: DrGaP (RRID:SCR_008670) Copy   

•   Source: SciCrunch Registry

http://www.danga.com/memcached/

A commercial distributed memory object caching system, generic in nature, but originally intended for use in speeding up dynamic web applications by alleviating database load. memcached allows you to take memory from parts of your system where you have more than you need and make it accessible to areas where you have less than you need. With memcached, you can see that all of the servers are looking into the same virtual pool of memory. This means that a given item is always stored and always retrieved from the same location in your entire web cluster.

Proper citation: Memached (RRID:SCR_008625) Copy   

•   Source: SciCrunch Registry

http://www.apache.org/

Provides support for the Apache community of open-source software projects. The Apache projects are characterized by a collaborative, consensus based development process, open and pragmatic software license, and a desire to create high quality software that leads the way in its field.

Proper citation: Apache Software Foundation (RRID:SCR_008588) Copy   

•   Source: SciCrunch Registry

http://www.gnuplot.info/

Gnuplot is a portable command-line driven graphing utility for linux, OS/2, MS Windows, OSX, VMS, and many other platforms. The source code is copyrighted but freely distributed (i.e., you don''t have to pay for it). It was originally created to allow scientists and students to visualize mathematical functions and data interactively, but has grown to support many non-interactive uses such as web scripting. It is also used as a plotting engine by third-party applications like Octave. Gnuplot has been supported and under active development since 1986. Gnuplot supports many types of plots in either 2D and 3D. It can draw using lines, points, boxes, contours, vector fields, surfaces, and various associated text. It also supports various specialized plot types. Demos here. Gnuplot supports many different types of output: interactive screen terminals (with mouse and hotkey input), direct output to pen plotters or modern printers, and output to many file formats (eps, fig, jpeg, LaTeX, metafont, pbm, pdf, png, postscript, svg, ...). Gnuplot is easily extensible to include new output modes. Recent additions include an interactive terminal based on wxWidgets and the creation of mousable graphs for web display using the HTML5 canvas element.

Proper citation: Gnuplot (RRID:SCR_008619) Copy   

•   Source: SciCrunch Registry

http://www.broadinstitute.org/cancer/cga/invex/

A permutation-based method (written in Python) for ascertaining genes with a somatic mutation distribution showing evidence of positive selection for non-silent mutations.

Proper citation: InVEx (RRID:SCR_008734) Copy   

•   Source: SciCrunch Registry

http://www.scangrants.com/

A listing of grants and other funding types to support health research, programs and scholarship. Funding sources most frequently listed on ScanGrants include those of private foundations, corporations, businesses, and not-for profit organizations. Finding and listing less traditional funding opportunities is also a priority. Federal and state funding sources are typically not included on ScanGrants because they are readily available on other sites (e.g., www.grants.gov). The funding sources listed on ScanGrants may be of interest to virtually anyone associated with the health field medical researchers, social workers, nurses, students, community-based health educators, academics and others. They include grants, scholarships, fellowships, prizes for scientific achievement or distinguished service, travel awards to professional meetings, abstract, essay and poster awards among other sources of funding. ScanGrants is a free resource that lists funding opportunities for researchers and students at many stages of their research projects or careers. Examples include: poster awards for completed projects; travel grants that could help finance trips to meetings that would enable you to discuss with peers in your field projects you are contemplating undertaking or in the midst of; calls for nominations for science prizes you could nominate colleagues you admire for; and announcements of funding for programs for violence or disease prevention. We invite you to give ScanGrants a try. If you would like your grant or scholarship announcement reviewed for possible posting on ScanGrants, please fill out the form with your name, email address, link to the original online listing of the funding opportunity, the title of the grant or scholarship and as much additional detail as possible.

Proper citation: ScanGrants (RRID:SCR_008736) Copy   

•   Source: SciCrunch Registry

http://www.moffitt.org/

H. Lee Moffitt Cancer Center & Research Institute has made a lasting commitment to the prevention and cure of cancer, working tirelessly in the areas of patient care, research and education to advance one step further in fighting this disease. As part of an elite group of National Cancer Institute (NCI) Comprehensive Cancer Centers, Moffitt focuses on the development of early stage translational research aimed at the rapid translation of scientific discoveries to benefit patient care. Since the first patient admission in October 1986, Moffitt physicians, scientists and staff members have worked together to establish a tradition of excellence offered in an atmosphere characterized by kindness, caring and hope. The Cancer Center''s future growth in clinical care and research rests firmly on this tradition and makes possible the changes ahead. The mission of Moffitt Cancer Center is to contribute to the prevention and cure of cancer. Moffitt''s vision is to be the leader in scientific discovery and translation into compassionate care, cures, and prevention of cancer for our community and the world. As it grows to fulfill its mission, the Cancer Center will continue to be distinguished by its compassionate and effective patient care. Moffitt Cancer Center is a not-for-profit institution. It includes private patient rooms, the Southeast''s largest Blood and Marrow Transplant Program, outpatient treatment programs that record more than 320,500 visits a year, the Moffitt Research Center, Moffitt Cancer Center at International Plaza and the Lifetime Cancer Screening & Prevention Center.

Proper citation: Moffitt Cancer Center (RRID:SCR_008730) Copy   

•   Source: SciCrunch Registry

http://helix.wustl.edu/dcaps/dcaps.html

A simple program for finding nearly matched primers Sponsor: This material is based upon work supported by the National Science Foundation under Grant No. 0114726.

Proper citation: dCAPS Finder (RRID:SCR_008612) Copy   

•   Source: SciCrunch Registry

http://www.rulesbasedmedicine.com/

Rules-Based Medicine (RBM) uses proprietary Multi-Analyte Profiling (MAP) technology to make life science research and drug and diagnostic development programs more efficient and effective. Whether measuring hundreds of biomarkers or simply a few, our approach provides reproducible, quantitative immunoassay data from a small sample volume at a cost-effective price. RBM is CLIA certified and supports GLP studies. * Quality: All immunoassays are validated to clinical laboratory standards. This means complete validation for the clinic, not fit for purpose validation which at RBM means inferior validation. Learn More * Content: We have the most comprehensive menu of biomarker immunoassays available. * Small Sample Volumes: Multiplexing provides you with more data using a smaller sample volume. * Cost Effective: Multiplexing and automation combine to deliver high quality data at reasonable prices. * Ease of use: Ship us your samples and get results within 2 weeks. Rules-Based Medicine (RBM), the worlds leading multiplexed biomarker testing laboratory, provides comprehensive protein biomarker products and services based on its Multi-Analyte Profiling (MAP) technology platform. RBMs biomarker testing service provides pre-clinical and clinical researchers with reproducible, quantitative, multiplexed immunoassay data for hundreds of proteins in a cost-effective manner, from a small sample volume and from multiple species. Our biomarker testing laboratory is CLIA certified and supports GLP studies. Most diseases and drug effects manifest themselves in abnormal levels of specific biomarkers found in the peripheral blood. By providing multiplexed, quantitative, and reproducible tests for hundreds of biomarkers, RBM enables research that historically was not available due to sample volume requirements and associated costs. Use of our testing services can identify the sources of both the positive and negative effects of drugs during pre-clinical research and clinical trials. Biomarker testing results identify patients most likely to respond to a given therapy and the biochemical reason for that response, making clinical trials more successful and effective. Through its wholly owned subsidiary EDI GmbH, RBM provides Human Organo-Typic (HOT) cell culture systems. These co-culture systems consist of multiple primary cell types grown in a 3-D architecture that closely mimic particular human organs and are an ideal platform for ex vivo studies of drug safety and efficacy. RBM combines EDIs cell culture systems with its HumanMAP biomarker testing services to provide researchers with an unprecedented view of the physiological and biochemical impact of a new drug compound or consumer product prior to testing in a human subject. RBM also performs custom assay development, participates in co-sponsored research programs, and pursues in-licensing of novel high-value assays.

Proper citation: Rules Based Medicine (RRID:SCR_008575) Copy   

•   Source: SciCrunch Registry

http://www.braintelemetry.com

The LVC64 accepts 64 microvolt-level buffered input signals from headstage preamps and serves as a 24-bit recording device. It is connected to a PC with an USB2.0 cable and provides a complete digital system to record broadband bioelectric signals. It has two parts such as a 64-channel ADC unit and a digital interface & power supply unit. Between these units there is a slip ring commutator and a DC motor. The main features of the LVC system include: Up to 128 Analog inputs per system; Each Analog input is sampled with an individual 24 bit delta-sigma A/D converter Analog inputs are simultaneously sampled at 1750 to 32000 samples per second In addition to multiple unit activity - the EEG, field potentials and behavioral marker signals are recorded simultaneously in the same file Full scale analog input range is 5 millivolts RMS (14 mV peak-to-peak) Analog inputs are differential inputs Extremely low input referred noise levels of max. 8 uV peak-to-peak Direct headstage tether and tether extension cable inputs Slip ring commutator for un-twisting the twisted tether cable Headstage power supplies Up to 24 bit TTL compatible Parallel Input Port for monitoring external signals and external Timestamp Clock input and output for multiple system synchronization Totally electrically isolated system from AC Power and Ground ''Microvolts-to-harddisk dumper'' data acquisition program running in host PC (32-bit MS Window XP) Online display of records during data acquisition in Host PC''s monitor Offline spike sorting by Cooperative Linux software of the Host PC

Proper citation: Braintelemetry (RRID:SCR_008607) Copy   

•   Source: SciCrunch Registry

http://www.aniara.com

An Antibody supplier

Proper citation: Aniara (RRID:SCR_008885) Copy   

•   Source: SciCrunch Registry

http://www.mcmillenfoundation.org/

A foundation that offers grants for researchers in cardiology, lipid and organ transplant in Washington and Alaska. The Robert B McMillen Foundation is a non-profit charitable foundation established to; promote research in the areas of cardiology, lipid and organ transplant, support education at the university and college level in the states of Washington and Alaska and provide funding for social service organizations. What we fund: * MEDICAL: 50% of our annual giving is earmarked for medical research. We will consider making grants to non-profit organizations involved in researching cardiology, lipid and organ transplants. * EDUCATION: 25% of our annual giving is earmarked for Education at the University level in the states of Washington and Alaska. Funding will be provided to support the art departments of post secondary schools who offer a degree in the visual arts. * SOCIAL: 25% of our annual giving is earmarked for social areas including, but not limited to, Goodwill, Salvation Army & United Way. Preference is given to organizations and/or programs that use art as the vehicle to impact communities and change individual lives.

Proper citation: McMillen Foundation (RRID:SCR_008908) Copy   

•   Source: SciCrunch Registry

http://www.kavlifoundation.org/

The Kavli Foundation, based in Oxnard, California, is dedicated to advancing science for the benefit of humanity, promoting public understanding of scientific research, and supporting scientists and their work. The Foundation''s mission is implemented through an international program of research institutes, professorships, symposia and other initiatives in the fields of astrophysics, nanoscience, neuroscience and theoretical physics. The Foundation is also a founding partner of the Kavli Prizes, which recognize scientists for their seminal advances in astrophysics, nanoscience and neuroscience. To date, The Kavli Foundation has made grants to establish Kavli Institutes on the campuses of the University of California Santa Barbara, Stanford University, the California Institute of Technology, the University of Chicago, Columbia University, Yale University, Cornell University, the University of California San Diego, Delft University of Technology in the Netherlands, the Massachusetts Institute of Technology, Peking University, the Chinese Academy of Sciences, Harvard University, the University of Cambridge and the Norwegian University of Science and Technology. In addition to the Kavli Institutes, six Kavli professorships have been established: two at the University of California Santa Barbara, one at University of California Los Angeles, one at the University of California Irvine, one at Columbia University, and one at the California Institute of Technology. The Kavli Futures Symposia a series of high quality scientific symposia on topics of emerging importance in the fields of astrophysics, nanoscience and neuroscience. The Frontiers of Science symposia bring together some of the very best young scientists across many disciplines to share and discuss exciting advances and opportunities in their fields. Videos and feature pieces have been created for teachers and students. This includes video interviews with acclaimed researchers Eric Kandel, M.D. and Edvard and May-Britt Moser, a video introduction and panel discussion on neuroscience, feature stories, written science overview, institute profiles and other materials. The Kavli Foundation is a private foundation qualified under IRC Section 501 (c) (3).

Proper citation: Kavli Foundation (RRID:SCR_005113) Copy   

•   Source: SciCrunch Registry

http://www.laskerfoundation.org/index.htm

The Albert and Mary Lasker Foundation and its programs are dedicated to the support of biomedical research toward conquering disease, improving human health and extending life. The Foundation''s mission is to foster the prevention and treatment of disease and disabilities by honoring excellence in basic and clinical science, by educating the public, and by advocating for support of medical research. The Lasker Awards The Lasker Foundation''s Awards Program recognizes the contributions of scientists, physicians, and public servants who have made major advances in the understanding, diagnosis, treatment, cure or prevention of human disease. Other Programs Although the Lasker Foundation is not a grant-giving organization, it does support select initiatives that raise awareness of medical discoveries and their benefits to human health, and that increase support for the medical science enterprise. These initiatives have included study groups, Congressional briefings, innovative web-based programs, educational forums, and scholarly studies.

Proper citation: Lasker Foundation (RRID:SCR_005114) Copy   

•   Source: SciCrunch Registry

http://bioinformatics.wistar.upenn.edu/isoformex

Software that estimates transcript expression levels and gene expression levels from mRNA-Seq data. Technically speaking, IsoformEx parses bowtie alignment files in a project directory (e.g. ~yourid/isoformex/xxx, where xxx is the project name) and generates two files: (1) xxx/xxx_transcript_1.txt: expression levels of all transcripts, (2) xxx/xxx_gene_1.txt: expression levels of all genes.

Proper citation: IsoformEx (RRID:SCR_005235) Copy   

•   Source: SciCrunch Registry